5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | NEUTRAL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.84▲ | 0.84▲ | 0.84▲ | 0.85▲ | 0.91▼ |
MA10 | 0.85▲ | 0.86▲ | 0.87▲ | 0.90▲ | 0.97▼ |
MA20 | 0.88▲ | 0.90▲ | 0.90▲ | 0.90▲ | 1.04▼ |
MA50 | 0.92▼ | 0.91▼ | 0.91▼ | 1.00▼ | 1.79▼ |
MA100 | 0.92▼ | 0.93▼ | 0.96▼ | 1.03▼ | 2.89▼ |
MA200 | 0.97▼ | 1.07▼ | 1.14▼ | 1.51▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.002▲ | -0.001▼ | -0.002▼ | -0.003▼ | 0.034▲ |
RSI | 53.448▲ | 51.999▲ | 51.456▲ | 48.740▼ | 40.274▼ |
STOCH | 32.655 | 29.338 | 29.338 | 25.879 | 8.433▼ |
WILL %R | -19.986▲ | -19.986▲ | -30.742 | -51.061 | -93.726▼ |
CCI | 48.153 | 47.252 | 36.886 | -55.080 | -72.099 |
Thursday, May 16, 2024 05:49 AM
Enbridge (NYSE:ENB) said Thursday it submitted filings to Canadian and U.S. securities regulators that would allow an at-the-market equity issuance program to sell as much as C$2.75B of its shares or ...
|
Wednesday, May 15, 2024 08:12 AM
Enbridge Inc. published its 2023 Sustainability Report. This report provides an overview of the Company's strategy and approach on sustainability, and details progress towards achieving its ...
|
Wednesday, May 15, 2024 03:47 AM
Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel neuroplastogenic ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/05/24 | 0.81 | 0.905 | 0.81 | 0.9049 | 1,165,504 |
15/05/24 | 0.815 | 0.815 | 0.785 | 0.788 | 181,788 |
14/05/24 | 0.8154 | 0.85 | 0.80 | 0.8205 | 733,370 |
13/05/24 | 0.861 | 0.862 | 0.861 | 0.862 | 392,206 |
10/05/24 | 0.899 | 0.94 | 0.8765 | 0.89 | 690,195 |
09/05/24 | 0.9044 | 0.99 | 0.901 | 0.92 | 951,008 |
08/05/24 | 1.01 | 1.03 | 0.8249 | 0.98 | 19,176,355 |
07/05/24 | 0.90 | 0.94 | 0.88 | 0.89 | 94,276 |
06/05/24 | 0.975 | 0.98 | 0.90 | 0.92 | 91,102 |
03/05/24 | 0.9231 | 1.02 | 0.9231 | 0.98 | 210,159 |
|
|
||||
|
|
||||
|
|